Search results
What Is Thyroid Eye Disease?
Health via Yahoo News· 4 months agoThyroid eye disease (TED) is an autoimmune condition that causes swelling and damage to the tissues around your eyes. There are two phases of TED: an...
At Higher Dose, Viridian's Thyroid Eye Disease Candidate Shows Significant, Rapid Improvement In...
Benzinga via Yahoo Finance· 2 years agoViridian Therapeutics Inc (NASDAQ: VRDN) announced topline clinical data from the first two cohorts...
Olympic Track Star Gail Devers Opens Up About Living with Graves' Disease and Thyroid Eye Disease
People via Yahoo News· 2 years agojessica McGowan Gail Devers was at the peak of her collegiate running career at UCLA when her health...
Viridian's Thyroid Eye Disease Candidate Shows Encouraging Early Data, Shares Surge
Benzinga via Yahoo Finance· 2 years agoViridian Therapeutics Inc (NASDAQ: VRDN) has announced initial data from the 10mg/kg cohort in its...
Horizon's (HZNP) Tepezza Study in Japan for TED Meets Goal
Zacks via Yahoo Finance· 12 months agoHorizon (HZNP) announces positive top-line results from its phase III study evaluating Tepezza for...
Olympic track star Gail Devers reflects on battle with Graves’ and thyroid eye diseases
TheGrio via Yahoo News· 2 years agoOlympic track star Gail Devers is speaking out about her longtime battle with Graves’ disease and...
Focus on Eyes: Thyroid eye disease can cause a range of problems, but it is treatable
Florida Today via Yahoo News· 2 years agoSupport local journalism. A digital subscription is incredibly affordable and makes you the most informed person around. Click here and subscribe today. Thyroid eye disease (TED) is an autoimmune ...
NBA All-star mom Wanda Durant is Spreading the Word About Graves' Disease
The Root via Yahoo News· 2 years agoWanda Durant is a mom of two successful sons: Anthony and Kevin (the latter just happens to be an...
Horizon (HZNP) Completes Enrollment in Phase IV TED Study
Zacks via Yahoo Finance· 2 years agoHorizon (HZNP) completes enrollment in the phase IV study evaluating Tepezza for the treatment of...
New Contender Viridian Takes Aim At Horizon's Eye Drug, And Rockets
Investor's Business Daily· 2 years agoViridian Therapeutics unveiled promising results Monday for its Horizon Therapeutics-rivaling...